| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |